Literature DB >> 23939377

PI3K stimulates DNA synthesis and cell-cycle progression via its p55PIK regulatory subunit interaction with PCNA.

Guihua Wang1, Xiaonian Cao, Senyan Lai, Xuelai Luo, Yongdong Feng, Xianmin Xia, Paul M Yen, Jianping Gong, Junbo Hu.   

Abstract

Previously, we have shown that p55PIK, an isoform of class I(A) phosphoinositide 3-kinase (PI3K), specifically interacts with important cell-cycle regulators, such as retinoblastoma (Rb), to promote cell-cycle progression. Here, we used the glutathione S-transferase pull-down assay to identify other p55PIK-interacting proteins besides Rb in a Rb-deficient cell line and found that p55PIK interacted with proliferation cell nuclear antigen (PCNA), which plays a key role in coordinating both initiation of the leading strand DNA replication and discontinuous lagging strand synthesis. Overexpression of p55PIK increased, and knockdown decreased, DNA synthesis and DNA replication by modulating the binding of DNA polymerase δ (Polδ) to PCNA. Moreover, a cell-permeable peptide containing the N-terminal-binding domain of p55PIK (TAT-N24) disrupted the p55PIK-PCNA interaction in cancer cells, and also inhibited the DNA synthesis and tumor growth in cell culture and in vivo. Altogether, our results show that the p55PIK-PCNA interaction is important in regulating DNA synthesis and contributes to tumorigenesis. Furthermore, the p55PIK-PCNA interaction provides a potential new target for anticancer drug development. ©2013 AACR.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23939377     DOI: 10.1158/1535-7163.MCT-12-0920

Source DB:  PubMed          Journal:  Mol Cancer Ther        ISSN: 1535-7163            Impact factor:   6.261


  13 in total

1.  MicroRNA-432 targeting E2F3 and P55PIK inhibits myogenesis through PI3K/AKT/mTOR signaling pathway.

Authors:  Meilin Ma; Xiangming Wang; Xiaochang Chen; Rui Cai; Fenfen Chen; Wuzi Dong; Gongshe Yang; Weijun Pang
Journal:  RNA Biol       Date:  2017-01-13       Impact factor: 4.652

2.  Role of the p55-gamma subunit of PI3K in ALK-induced cell migration: RNAi-based selection of cell migration regulators.

Authors:  Minchul Seo; Jong-Heon Kim; Kyoungho Suk
Journal:  Cell Adh Migr       Date:  2016-06-20       Impact factor: 3.405

3.  Bone morphogenetic protein 2 inhibits hepatocellular carcinoma growth and migration through downregulation of the PI3K/AKT pathway.

Authors:  Ying Zheng; Xuemei Wang; Haidong Wang; Wei Yan; Quan Zhang; Xin Chang
Journal:  Tumour Biol       Date:  2014-02-27

4.  PIK3R3 promotes chemotherapeutic sensitivity of colorectal cancer through PIK3R3/NF-kB/TP pathway.

Authors:  Sidikjan Ibrahim; Guodong Li; Fuqing Hu; Zhenlin Hou; Qianzhi Chen; Geng Li; Xuelai Luo; Junbo Hu; Yongdong Feng
Journal:  Cancer Biol Ther       Date:  2018-01-25       Impact factor: 4.742

5.  PIK3R3 regulates PPARα expression to stimulate fatty acid β-oxidation and decrease hepatosteatosis.

Authors:  Xi Yang; Yinjia Fu; Fuqing Hu; Xuelai Luo; Junbo Hu; Guihua Wang
Journal:  Exp Mol Med       Date:  2018-01-19       Impact factor: 8.718

6.  Dual Roles of Ascidian Chondromodulin-1: Promoting Cell Proliferation Whilst Suppressing the Growth of Tumor Cells.

Authors:  Xiaoju Dou; Xiang Li; Haiyan Yu; Bo Dong
Journal:  Mar Drugs       Date:  2018-02-11       Impact factor: 5.118

7.  Histone demethylase KDM4D promotes gastrointestinal stromal tumor progression through HIF1β/VEGFA signalling.

Authors:  Fuqing Hu; Haijie Li; Lu Liu; Feng Xu; Senyan Lai; Xuelai Luo; Junbo Hu; Xi Yang
Journal:  Mol Cancer       Date:  2018-07-30       Impact factor: 27.401

8.  P55PIK Regulates P53-Dependent Apoptosis in Cancer Cells by Interacting with P53 DNA-Specific Domain.

Authors:  Chaoxing Li; Wenwen Li; Xiyao Cheng; Dapeng Zhang; Xiang Sun; Jingjing Zhou; Yin Zhou; Yongqi Huang; Xianmin Xia; Qi Ma; Zhengding Su
Journal:  Onco Targets Ther       Date:  2020-06-08       Impact factor: 4.147

9.  KIT over-expression by p55PIK-PI3K leads to Imatinib-resistance in patients with gastrointestinal stromal tumors.

Authors:  Senyan Lai; Guihua Wang; Xiaonian Cao; Xuelai Luo; Guoping Wang; Xianmin Xia; Junbo Hu; Jing Wang
Journal:  Oncotarget       Date:  2016-01-12

10.  The Novel Phosphatidylinositol-3-Kinase (PI3K) Inhibitor Alpelisib Effectively Inhibits Growth of PTEN-Haploinsufficient Lipoma Cells.

Authors:  Anna S Kirstein; Adrien Augustin; Melanie Penke; Michele Cea; Antje Körner; Wieland Kiess; Antje Garten
Journal:  Cancers (Basel)       Date:  2019-10-17       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.